BR9909480A - Método para gerar uma resposta à célula t citotóxica de um especìfico hiv em um hospedeiro - Google Patents
Método para gerar uma resposta à célula t citotóxica de um especìfico hiv em um hospedeiroInfo
- Publication number
- BR9909480A BR9909480A BR9909480-0A BR9909480A BR9909480A BR 9909480 A BR9909480 A BR 9909480A BR 9909480 A BR9909480 A BR 9909480A BR 9909480 A BR9909480 A BR 9909480A
- Authority
- BR
- Brazil
- Prior art keywords
- host
- generating
- hiv
- cytotoxic
- cell
- Prior art date
Links
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 title abstract 2
- 230000005867 T cell response Effects 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
"MéTODO PARA GERAR UMA RESPOSTA à CéLULA T CITOTóXICA DE UM ESPECìFICO HIV EM UM HOSPEDEIRO". Método para gerar uma resposta à célula T citotóxica de um específico HIV em um hospedeiro, que envolve uma administração inicial de uma molécula auxiliadora T ao hospedeiro, a fim de preparar as células auxiliadoras T do sistema imunológico do hospedeiro e uma administração subseq³ente ao hospedeiro de uma mistura da molécula auxiliadora T e uma célula T, que induz a molécula derivada HIV, a gerar uma resposta à célula T específica de HIV no hospedeiro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/055,744 US20010019714A1 (en) | 1998-04-07 | 1998-04-07 | Hiv-specific cytotoxic t-cell responses |
PCT/CA1999/000287 WO1999051267A1 (en) | 1998-04-07 | 1999-04-01 | Hiv-specific cytotoxic t-cell responses |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909480A true BR9909480A (pt) | 2001-10-16 |
Family
ID=21999878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909480-0A BR9909480A (pt) | 1998-04-07 | 1999-04-01 | Método para gerar uma resposta à célula t citotóxica de um especìfico hiv em um hospedeiro |
Country Status (8)
Country | Link |
---|---|
US (1) | US20010019714A1 (pt) |
EP (1) | EP1067963A1 (pt) |
JP (1) | JP3996349B2 (pt) |
AU (1) | AU759183B2 (pt) |
BR (1) | BR9909480A (pt) |
CA (1) | CA2324983A1 (pt) |
NZ (1) | NZ507742A (pt) |
WO (1) | WO1999051267A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12016844B2 (en) | 2019-07-02 | 2024-06-25 | Virago Vax Inc. | Mammary tumor virus suppression |
US12029783B2 (en) | 2019-07-02 | 2024-07-09 | Virago Vax Inc. | Mammary tumor virus vaccine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE320444T1 (de) * | 1991-08-26 | 2006-04-15 | Scripps Research Inst | Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren |
WO1993003764A1 (en) * | 1991-08-26 | 1993-03-04 | Cytel Corporation | Hla-restricted hepatitis b virus ctl epitopes |
US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
US6024965A (en) * | 1996-10-18 | 2000-02-15 | Erasums University Rotterdam | Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection |
US7105164B1 (en) * | 1998-04-07 | 2006-09-12 | Sanofi Pasteur Limited | HIV-specific cytotoxic T-cell responses |
-
1998
- 1998-04-07 US US09/055,744 patent/US20010019714A1/en not_active Abandoned
-
1999
- 1999-04-01 AU AU30220/99A patent/AU759183B2/en not_active Ceased
- 1999-04-01 WO PCT/CA1999/000287 patent/WO1999051267A1/en not_active Application Discontinuation
- 1999-04-01 JP JP2000542037A patent/JP3996349B2/ja not_active Expired - Fee Related
- 1999-04-01 BR BR9909480-0A patent/BR9909480A/pt not_active Application Discontinuation
- 1999-04-01 EP EP99911556A patent/EP1067963A1/en not_active Withdrawn
- 1999-04-01 CA CA002324983A patent/CA2324983A1/en not_active Abandoned
- 1999-04-01 NZ NZ507742A patent/NZ507742A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ507742A (en) | 2003-11-28 |
CA2324983A1 (en) | 1999-10-14 |
US20010019714A1 (en) | 2001-09-06 |
JP3996349B2 (ja) | 2007-10-24 |
EP1067963A1 (en) | 2001-01-17 |
JP2002510650A (ja) | 2002-04-09 |
WO1999051267A1 (en) | 1999-10-14 |
AU759183B2 (en) | 2003-04-10 |
AU3022099A (en) | 1999-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025621L (no) | Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser | |
BR0009580A (pt) | Composição, processos para preparar vìrus da influenza, para preparar um veìculo de liberação de genes, para preparar vìrus da influenza defeituosos de replicação infecciosa, para imunizar um paciente contra um patógeno, para preparar vìrus infeccioso, e para preparar vìrus, vìrus, célula, vetor, célula hospedeira, e, uso do vìrus | |
GR3034204T3 (en) | Lipopolyamines as transfection agents and pharmaceutical uses thereof | |
UY27552A1 (es) | 17a- alquil- 17b- oxi-estratrienos y productos intermediarios para su preparacinn, uso de los 17a-alquil-17b-oxi-estratrienos para obtener medicamentos y preparados farmacéuticos. | |
HK1142093A1 (en) | Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | |
BR9911163A (pt) | Formulação de vacina, formulação farmacêutica, vìrus atenuado de influenza, processos para vacinar um indivìduo, para prevenir uma doença infecciosa em um indivìduo, e, para tratar ou prevenir tumores em um indivìduo | |
FI953442A (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
ITRM920590A0 (it) | Sistema per la realizzazione distrutture in fibra di carbonio, e procedimento per detto, particolarmente idoneo per applicazioni aeronautiche. | |
ES2194989T3 (es) | Composicion adminstrada por via oral, que comprende una toxina de zonula occludens y un agente que tiene una actividad biologica, y su utilizacion. | |
BRPI9809791B8 (pt) | compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos | |
ZA936629B (en) | Potentiation of immunogenic response | |
ATE202931T1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
BRPI0409761A (pt) | complexo de um composto farmacêutico, formulação oral, derivado de fosfatidila de um composto farmacêutico, método para a preparação de um derivado de fosfato de um composto farmacêutico, derivado de fosfato de um composto farmacêutico e uso do mesmo | |
AU5658196A (en) | Method for pharmaceutical delivery | |
YU166790A (sh) | Kompleksi koji imaju pomoćnu aktivnost | |
BR9915215A (pt) | Composição farmacêutica para liberação modificada de sensibilizador de insulina | |
ATE234082T1 (de) | Adenosin enthaltendes arzneimittel | |
DK0737069T3 (da) | Deuterede aktive stoffer til transdermal administrering | |
BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
BR9909480A (pt) | Método para gerar uma resposta à célula t citotóxica de um especìfico hiv em um hospedeiro | |
DE69912827D1 (de) | "ligand presenting assembly" (lpa), verfahren zu dessen herstellung und verwendungen | |
DE59708495D1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
DE69804766D1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
BG104452A (en) | New derivatives of the methylenebisphosphonic acid | |
BR0013574A (pt) | Antìgeno vacina de moraxella |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (IX), 11 E 13 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |